This is a routine investor relations filing with no trading signal. Monitor for future pipeline updates or financing events, as the company has a $19M market cap and no disclosed revenue.
Price Chart
Executive Summary
Dare Bioscience filed an 8-K with a corporate investor presentation dated July 24, 2026, under Item 7.01 Regulation FD. The filing is a routine disclosure of a presentation deck used for meetings with market participants; it contains no new material financial data, guidance, or operational updates. For a $19M market cap biotech with no revenue or pipeline catalysts disclosed, this is a non-event.
Key Facts
- Filed 8-K on July 24, 2026, furnishing a corporate presentation (Exhibit 99.1) under Item 7.01 Regulation FD.
- Presentation is intended for use in meetings with securities market participants; no new financial results or guidance provided.
- No material agreements, financial data, or operational milestones were disclosed in the filing.
Financial Impact
No financial impact — filing contains no revenue, earnings, or guidance figures.
Risk Factors
- No material information disclosed; stock may be driven by unrelated news or sentiment.
- Micro-cap biotech with no revenue carries inherent financing and clinical risk.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-034483 |
| Document: 0001493152-26-034483-index-headers.html | 0001493152-26-034483 |
| Document: 0001493152-26-034483-index.html | 0001493152-26-034483 |
| Document: 0001493152-26-034483.txt | 0001493152-26-034483 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 6, 2026 19d ago | DEF 14A | $0.7900 $0.7720 | ▲ +2.28% | ▲ +1.86% | $0.6467 (+18.14%) |
Oct 1, 2026 25d ago | 8-K | $0.8510 $0.8428 | ▼ −0.96% | ▼ −1.70% | $0.6467 (−24.01%) |
Sep 9, 2026 6w ago | 8-K | $0.7166 $0.7051 | ▼ −1.60% | ▼ −1.01% | $0.6467 (−9.75%) |
Sep 4, 2026 7w ago | EFFECT | $0.7210 $0.7130 | ▲ +1.11% | ▲ +0.56% | $0.6467 (+10.31%) |
Aug 17, 2026 10w ago | 8-K | $0.8102 $0.7682 | ▲ +5.18% | ▲ +4.51% | $0.6467 (+20.18%) |
Aug 17, 2026 10w ago | 424B5 | $0.8102 $0.7682 | ▲ +5.18% | ▲ +4.51% | $0.6467 (+20.18%) |
Aug 13, 2026 10w ago | 8-K | $0.9300 $0.8102 | ▼ −12.88% | ▼ −12.41% | $0.6467 (−30.46%) |
Aug 6, 2026 11w ago | Press Release | $1.33 $1.40 | ▲ +5.26% | ▲ +4.65% | $0.6467 (−51.38%) |
Jul 24, 2026 13w ago | 8-K | $1.28 $1.32 | ▲ +3.13% | ▲ +3.10% | $0.6467 (−49.48%) |
Jul 13, 2026 15w ago | 8-K | $2.09 $2.07 | ▼ −0.96% | ▼ −1.31% | $0.6467 (−69.06%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers